Abstract
The process of skin repair after injury is complex and fragile. Deficiencies in any of its phases can lead to the formation of chronic nonhealing wounds. Diabetes mellitus is often a major contributing factor for chronic wounds, which cause significant suffering in patients, and are a serious burden for healthcare providers. The management of chronic diabetic wounds remains a considerable challenge; therefore, the search for an effective treatment is of great importance. Erythropoietin (EPO) is generating increasing interest for promoting wound healing and may lead to the development of a new paradigm for treatment of wounds. This article focuses on the beneficial effects of EPO on tissue regeneration during the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
